Unique Ingredient Identifier 288VBX44JC is listed as a ingredient substance
| RN | 9004-65-3 |
| RXCUI | 1300451 |
| MF | Polymer substance not supported |
UNII 288VBX44JC HYPROMELLOSE 2910 (15000 MPA.S) is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| NASAL | SPRAY, METERED | 0.1 % |
| OPHTHALMIC | SOLUTION | 0.5 % |
| OPHTHALMIC | SUSPENSION | 0.5 % |
| OPHTHALMIC | SUSPENSION, DROPS | 0.5 % |
| ORAL | CAPSULE | 40.55 MG |
| ORAL | CAPSULE, DELAYED ACTION | 33.42 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 13.82 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 10.6 MG |
| ORAL | CAPSULE, HARD GELATIN | 2 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 21.1 MG |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 4.77 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 26.6 MG |
| ORAL | POWDER, FOR RECONSTITUTION | 79.65 MG/5ML |
| ORAL | POWDER, FOR SOLUTION | 2398.2 MG/1BOT |
| ORAL | POWDER, FOR SUSPENSION | 30 MG/1SCP |
| ORAL | SOLUTION, SYRUP | 24 MG/1ML |
| ORAL | SUSPENSION | 5 MG/1ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 24.08 MG/.20684GM |
| ORAL | SYRUP | 5 MG/1ML |
| ORAL | TABLET | 1943 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 214.5 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 11.8 MG |
| ORAL | TABLET, COATED | 29.25 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 20 MG |
| ORAL | TABLET, DELAYED ACTION | 4.47 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 19 MG |
| ORAL | TABLET, ENTERIC COATED PARTICLES | 445 MG |
| ORAL | TABLET, EXTENDED RELEASE | 150 MG |
| ORAL | TABLET, FILM COATED | 60 MG |
| ORAL | TABLET, MULTILAYER, COATED | 22 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 25 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 7 MG |
| ORAL | TABLET, SUSTAINED ACTION | 250 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 6.7 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 54 MG |